Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
PLoS One ; 18(8): e0284487, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-37610980

RESUMEN

The notion of sobriety is considered a key variable in various energy transition scenarios. Often associated with a form of punitive ecology, it is, nevertheless, possible to make it a component that supports green growth, by linking it to the concept of "satisfaction". In this work, we have invented a way to achieve both "digital", "economic", and "ecological" sobriety, while ensuring the satisfaction of the end user. Directly correlated to the production of goods or services, the satisfaction function is built on the well-documented marginal utility function, which measures the need (or not) to consume further resources to satisfy the economic agents. Hence, it is justified and exists because it stands for the expectations of end users and makes sure the latter is met. This product itself is a function of the allocation of a set of resources, mapped using activity-based costing tools (ABC method). In this work, we focus on an AI proof-of-concept and demonstrate that it is possible to reach numerical sobriety by controlling the size of the training dataset while ensuring roughly the same model performance. In general, we show that it is possible to preserve the efficiency of AI processes while significantly minimizing the need for resources. In this sense, after establishing an analytical model, we suggest reducing the amount of data required to train the machine learning (ML) models, while guaranteeing zero change in terms of performance (say their accuracy). We show that it affects the energy consumed, and, thereby, the associated cost (i.e., economic and ecological) and the associated CO2eq emission. We thus confirm the existence of a "triangle of sobriety". It is defined as a virtual circle governed by a digital-economic-ecological sovereignty. We also propose that if AI production processes have a potential for sobriety, all identical activities have the same characteristics, thus opening the path to green growth.

2.
Int J Mol Sci ; 24(8)2023 Apr 17.
Artículo en Inglés | MEDLINE | ID: mdl-37108563

RESUMEN

Fractures cause extreme pain to patients and impair movement, thereby significantly reducing their quality of life. However, in fracture patients, movement of the fracture site is restricted through application of a cast, and they are reliant on conservative treatment through calcium intake. Persicae semen (PS) is the dried mature seeds of Prunus persica (L.) Batsch, and in this study the effects of PS on osteoblast differentiation and bone union promotion were investigated. The osteoblast-differentiation-promoting effect of PS was investigated through alizarin red S and Von Kossa staining, and the regulatory role of PS on BMP-2 (Bmp2) and Wnt (Wnt10b) signaling, representing a key mechanism, was demonstrated at the protein and mRNA levels. In addition, the bone-union-promoting effect of PS was investigated in rats with fractured femurs. The results of the cell experiments showed that PS promotes mineralization and upregulates RUNX2 through BMP-2 and Wnt signaling. PS induced the expression of various osteoblast genes, including Alpl, Bglap, and Ibsp. The results of animal experiments show that the PS group had improved bone union and upregulated expression of osteogenic genes. Overall, the results of this study suggest that PS can promote fracture recovery by upregulating osteoblast differentiation and bone formation, and thus can be considered a new therapeutic alternative for fracture patients.


Asunto(s)
Calidad de Vida , Vía de Señalización Wnt , Animales , Ratas , Proteína Morfogenética Ósea 2/genética , Proteína Morfogenética Ósea 2/farmacología , Proteína Morfogenética Ósea 2/metabolismo , Diferenciación Celular , Línea Celular , Osteoblastos/metabolismo , Osteogénesis , Semillas/metabolismo , Fracturas del Fémur/metabolismo
3.
BMC Complement Med Ther ; 20(1): 35, 2020 Feb 05.
Artículo en Inglés | MEDLINE | ID: mdl-32024503

RESUMEN

BACKGROUND: Osteoporosis is related to the number and activity of osteoclasts. The goal of the present study was to demonstrate the effect of Chaenomelis Fructus (CF) on osteoclastogenesis and its mechanism of bone loss prevention in an OVX-induced osteoporosis model. METHODS: Osteoclasts were induced by RANKL in RAW 264.7 cells. TRAP assay was performed to measure the inhibitory effect of CF on osteoclast differentiation. Then, Expression of nuclear factor of activated T-cells (NFATc1), c-Fos which are essential transcription factors in osteoclastogenesis were detected using western blot and RT-PCR. The osteoclast-related markers were measured by RT-PCR. Moreover, the ability of CF to inhibit bone loss was researched by ovariectomized (OVX)-induced osteoporosis. RESULTS: Cell experiments showed that CF inhibited osteoclast differentiation and its function. Immunoblot analyses demonstrated that CF suppressed osteoclastogenesis through the NFATc1 and c-Fos signaling pathways. RT-PCR determined that CF inhibited osteoclast-related markers, such as tartrate-resistant acid phosphatase (TRAP), cathepsin K (CTK), osteoclast-associated immunoglobulin-like receptor (OSCAR), ATPase H+ Transporting V0 Subunit D2 (ATP6v0d2) and carbonic anhydrase II (CA2). In animal experiments, CF showed an inhibitory effect on bone density reduction through OVX. Hematoxylin and eosin (H&E) staining analysis data showed that CF inhibited OVX-induced trabecular area loss. TRAP staining and immunohistochemical staining analysis data showed that CF displayed an inhibitory effect on osteoclast differentiation through NFATc1 inhibition in femoral tissue. CONCLUSION: Based on the results of in vivo and in vitro experiments, CF inhibited the RANKL-induced osteoclasts differentiation and its function and effectively ameliorated OVX-induced osteoporosis rats.


Asunto(s)
Factores de Transcripción NFATC/metabolismo , Osteoclastos/metabolismo , Osteogénesis/efectos de los fármacos , Osteoporosis/tratamiento farmacológico , Extractos Vegetales/farmacología , Rosaceae/química , Animales , Western Blotting , Densidad Ósea , Diferenciación Celular/efectos de los fármacos , Modelos Animales de Enfermedad , Femenino , Fémur/efectos de los fármacos , Frutas/química , Ratones , Osteoclastos/efectos de los fármacos , Ovariectomía , Células RAW 264.7 , Ratas Sprague-Dawley
4.
Bioinspir Biomim ; 10(4): 046008, 2015 Jul 07.
Artículo en Inglés | MEDLINE | ID: mdl-26151098

RESUMEN

Running with compliant curved legs involves the progression of the center of pressure, the changes of both the leg's stiffness and effective rest length, and the shift of the location of the maximum stress point along the leg. These phenomena are product of the geometric and material properties of these legs, and the rolling motion produced during stance. We examine these aspects with several reduced-order dynamical models to relate the leg's design parameters (such as normalized foot radius, leg's effective stiffness, location of the maximum stress point and leg shape) to running performance (such as robustness and efficiency). By using these models, we show that running with compliant curved legs can be more efficient, robust with fast recovery behavior from perturbations than running with compliant straight legs. Moreover, the running performance can be further improved by tuning these design parameters in the context of running with rolling. The results shown in this work may serve as potential guidance for future compliant curved leg designs that may further improve the running performance.


Asunto(s)
Biomimética/instrumentación , Pierna/fisiología , Modelos Biológicos , Esfuerzo Físico/fisiología , Robótica/instrumentación , Carrera/fisiología , Animales , Biomimética/métodos , Simulación por Computador , Módulo de Elasticidad/fisiología , Diseño de Equipo , Análisis de Falla de Equipo , Marcha/fisiología , Humanos , Estrés Mecánico
5.
Immunopharmacol Immunotoxicol ; 37(4): 351-8, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26121924

RESUMEN

Peiminine is the main biologically active component derived from Fritillaria ussuriensis. Peiminine was investigated in various pulmonary diseases, but its antiallergic effect and the related mechanism have not been reported yet. The present study aimed to evaluate the effect of peiminine on mast cell-mediated allergic inflammation in HMC-1 cells. The pro-inflammatory cytokine production was measured using ELISA, reverse transcription-polymerase chain reaction and nuclear factor-kappaB (NF-κB), mitogen-activated protein kinases (MAPKs) pathway activation, as determined by Western blot analysis. Peiminine inhibits the production of the pro-inflammatory cytokine, such as interleukin (IL)-6, IL-8, tumor necrosis factor-alpha (TNF-α) and IL-1beta (IL-1ß). It was shown to have inhibitory effects on MAPKs phosphorylation and NF-B expression in human mast cells (HMC)-1 using Western blot. HMC-1 cells were observed for confirmation of histamine release. Passive cutaneous anaphylaxis (PCA) reactions were evaluated using an animal model and peiminine demonstrated inhibitory effects on IgE-dependent anaphylaxis. These results suggest that peiminine has regulatory potential for allergic inflammatory reactions mediated by HMC-1 cells.


Asunto(s)
Antialérgicos/farmacología , Cevanas/farmacología , Liberación de Histamina/efectos de los fármacos , Mastocitos/efectos de los fármacos , Animales , Antialérgicos/administración & dosificación , Antialérgicos/química , Western Blotting , Técnicas de Cultivo de Célula , Línea Celular , Supervivencia Celular/efectos de los fármacos , Cevanas/administración & dosificación , Cevanas/química , Citocinas/inmunología , Ensayo de Inmunoadsorción Enzimática , Liberación de Histamina/inmunología , Humanos , Inmunoglobulina E/inmunología , Mastocitos/inmunología , Anafilaxis Cutánea Pasiva/inmunología , Ratas Sprague-Dawley , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA